Insys Therapeutics (INSY) Jumps as Epinephrine Nasal Spray Shows Early Promise for Anaphylaxis

June 14, 2018 1:06 PM
INSYS Therapeutics, Inc. (NASDAQ: INSY) is gaining 18% intra-day after the company announced that its investigational epinephrine nasal spray showed ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Momentum Movers Trader Talk

Next Articles